This observation was confirmed in experimental models, both in vivo in a mouse model of Braf-driven thyroid cancer, and in vitro, in FRTL5 rat thyroid cells either chronically or acutely transformed by oncogenic H-Ras, where we invariably found that Klhl14 is downregulated compared to normal cells. The gene discussed is HRAS; the disease is thyroid cancer.